C07C309/14

HYDROXYSULTAINE- AND SULFOBETAINE-BASED GEMINAL ZWITTERIONIC LIQUIDS, METHOD FOR OBTAINING SAME, AND USE THEREOF AS WETTABILITY MODIFIERS HAVING CORROSION INHIBITING PROPERTIES

The present invention is related to obtaining and using sulfobetaine and hidroxisultaine-based geminal zwitterionic liquids as wettability modifiers for rocks such as limestone, dolomite, sandstone, quartz or heterogeneous lithologies, under the presence of brines having high content of divalent ions as calcium, magnesium, barium and strontium, at high temperature and high pressure conditions for enhanced oil recovery processes to increase the oil production.

The geminal zwitterionic liquids of the present invention have also the property of acting as corrosion inhibitors of ferrous metals used in pipelines and equipment for crude oil extraction, production, transport and storage operations. A further advantage shown by zwitterionic liquids derived from their molecular structure is they can be dissolved in distilled water, brine, hydrocarbon solvents, aromatics and alcohols.

HYDROXYSULTAINE- AND SULFOBETAINE-BASED GEMINAL ZWITTERIONIC LIQUIDS, METHOD FOR OBTAINING SAME, AND USE THEREOF AS WETTABILITY MODIFIERS HAVING CORROSION INHIBITING PROPERTIES

The present invention is related to obtaining and using sulfobetaine and hidroxisultaine-based geminal zwitterionic liquids as wettability modifiers for rocks such as limestone, dolomite, sandstone, quartz or heterogeneous lithologies, under the presence of brines having high content of divalent ions as calcium, magnesium, barium and strontium, at high temperature and high pressure conditions for enhanced oil recovery processes to increase the oil production.

The geminal zwitterionic liquids of the present invention have also the property of acting as corrosion inhibitors of ferrous metals used in pipelines and equipment for crude oil extraction, production, transport and storage operations. A further advantage shown by zwitterionic liquids derived from their molecular structure is they can be dissolved in distilled water, brine, hydrocarbon solvents, aromatics and alcohols.

Biological Buffers with Wide Buffering Ranges
20170260435 · 2017-09-14 ·

Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

Biological Buffers with Wide Buffering Ranges
20170260435 · 2017-09-14 ·

Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS

The present disclosure provides one or more amino lipids such as an amino lipids containing a sulfonic acid or sulfonic acid derivative of the formulas:

##STR00001##

wherein the variables are as defined herein. These amino lipids may be used in compositions with one or more helper lipids and a nucleic acid therapeutic agent. These compositions may be used to treat a disease or disorder such as cancer, cystic fibrosis, or other genetic diseases.

CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS

The present disclosure provides one or more amino lipids such as an amino lipids containing a sulfonic acid or sulfonic acid derivative of the formulas:

##STR00001##

wherein the variables are as defined herein. These amino lipids may be used in compositions with one or more helper lipids and a nucleic acid therapeutic agent. These compositions may be used to treat a disease or disorder such as cancer, cystic fibrosis, or other genetic diseases.

METHODS AND COMPOSITIONS FOR DOWNHOLE DIVERSION OF WELL TREATMENT FLUID

In one aspect, embodiments disclosed herein relate to wellbore fluids that include a surfactant, calcium chloride, and an aqueous base fluid. The surfactant may have a structure represented by formula (I):

##STR00001##

where R.sup.1 is a C.sub.15-C.sub.27 hydrocarbon group, R.sup.2 is a C.sub.1-C.sub.10 hydrocarbon group, and n and m are each, independently, an integer ranging from 1 to 4. The wellbore fluid may contain the calcium chloride in an amount of 5% by weight (wt. %) or more, relative to the total weight of the wellbore fluid.

METHODS AND COMPOSITIONS FOR DOWNHOLE DIVERSION OF WELL TREATMENT FLUID

In one aspect, embodiments disclosed herein relate to wellbore fluids that include a surfactant, calcium chloride, and an aqueous base fluid. The surfactant may have a structure represented by formula (I):

##STR00001##

where R.sup.1 is a C.sub.15-C.sub.27 hydrocarbon group, R.sup.2 is a C.sub.1-C.sub.10 hydrocarbon group, and n and m are each, independently, an integer ranging from 1 to 4. The wellbore fluid may contain the calcium chloride in an amount of 5% by weight (wt. %) or more, relative to the total weight of the wellbore fluid.

NANOPARTICLE, CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING COMPRISING SAME AND ZWITTERIONIC LIGAND COMPOUND

Provided is a novel nanoparticle, a contrast agent for magnetic resonance imaging containing the same, and a zwitterionic ligand compound used in production of the nanoparticle. The contrast agent for MRI of the present invention can be suitably used as a contrast agent for MRI in a medical field. The nanoparticle and the zwitterionic ligand compound of the present invention are applicable to various pharmaceutical compositions and the like, including a contrast agent for MRI, and can be used widely in the fields of pharmaceuticals, biotechnology, and the like, including various diagnosis methods and examination reagents.

NANOPARTICLE, CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING COMPRISING SAME AND ZWITTERIONIC LIGAND COMPOUND

Provided is a novel nanoparticle, a contrast agent for magnetic resonance imaging containing the same, and a zwitterionic ligand compound used in production of the nanoparticle. The contrast agent for MRI of the present invention can be suitably used as a contrast agent for MRI in a medical field. The nanoparticle and the zwitterionic ligand compound of the present invention are applicable to various pharmaceutical compositions and the like, including a contrast agent for MRI, and can be used widely in the fields of pharmaceuticals, biotechnology, and the like, including various diagnosis methods and examination reagents.